Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor-Reference-Cited by-同舟云学术

Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor

Published:2010-02-15 Issue:2 Volume:1 Page:64-69
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Arasappan Ashok¹,Bennett Frank¹,Bogen Stephane L.¹,Venkatraman Srikanth¹,Blackman Melissa¹,Chen Kevin X.¹,Hendrata Siska¹,Huang Yuhua¹,Huelgas Regina M.¹,Nair Latha¹,Padilla Angela I.¹,Pan Weidong¹,Pike Russell¹,Pinto Patrick¹,Ruan Sumei¹,Sannigrahi Mousumi¹,Velazquez Francisco¹,Vibulbhan Bancha¹,Wu Wanli¹,Yang Weiying¹,Saksena Anil K.¹,Girijavallabhan Viyyoor¹,Shih Neng-Yang¹,Kong Jianshe¹,Meng Tao¹,Jin Yan¹,Wong Jesse¹,McNamara Paul¹,Prongay Andrew¹,Madison Vincent¹,Piwinski John J.¹,Cheng Kuo-Chi¹,Morrison Richard¹,Malcolm Bruce¹,Tong Xiao¹,Ralston Robert¹,Njoroge F. George¹

Affiliation:

1. Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml9000276

Reference23 articles.

1. The Scientific Challenge of Hepatitis C

2. The global burden of hepatitis C

3. Emerging therapies for hepatitis C virus infection

4. Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

3. Proline Analogues;Chemical Reviews;2024-06-28

4. Exploring theophylline-1,2,4-triazole tethered N-phenylacetamide derivatives as antimicrobial agents: unraveling mechanisms via structure-activity relationship, in vitro validation, and in silico insights;Frontiers in Chemistry;2024-04-05

5. Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic;Journal of Medicinal Chemistry;2024-02-16